Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $0.2701 (-14.9%) ($0.2701 - $0.2701) on Mon. May. 9, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 10.76% (three month average) | RSI | 33 | Latest Price | $0.2701(-14.9%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -6.1% a day on average for past five trading days. | Weekly Trend | ANPC declines -8.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) VFMO(93%) VT(92%) IWO(85%) IPO(82%) BLOK(81%) | Factors Impacting ANPC price | ANPC will decline at least -5.38% in a week (0% probabilities). BND(-36%) BNDX(-21%) XLU(-9%) VCIT(3%) VCSH(4%) | | | | | Relative Volatility | | | | Market Trend Strength | -5.38% (StdDev 10.76%) | Hourly BBV | -1.8 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-34.36(-12821.21%) | Resistance Level | $0.37 | 5 Day Moving Average | $0.31(-12.87%) | 10 Day Moving Average | $0.33(-18.15%) | 20 Day Moving Average | $0.37(-27%) | To recent high | -70.4% | To recent low | 0% | Market Cap | $2m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |